https://www.oncologynurseadvisor.com Wed, 03 Jan 2024 19:27:41 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/departments/issues-in-cancer-survivorship/cancer-patient-role-rumination-core-beliefs-diagnosis-treatment-risk/ Wed, 27 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115167 Researchers explored how rumination and core beliefs influenced patients’ psychological well-being after a cancer diagnosis.]]> https://www.oncologynurseadvisor.com/reports/acute-leukemia-aml-midh1-ivosidenib-venetoclax-comparison/ Wed, 20 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115094 This study aimed to compare treatment patterns, efficacy, and safety of 2 frontline regimens in a large cohort of patients with newly diagnosed mutant IDH1 AML.]]> https://www.oncologynurseadvisor.com/home/oncology-nursing/nurse-practitioner-satisfaction-person-telehealth-care-treatment-risk/ Tue, 19 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115042 An assessment of nurse practitioners’ preferences for in-person or telehealth care delivery showed mixed satisfaction, but most of those who provided both preferred in-person.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/lung-cancer-nsclc-patient-perspective-communication-symptom-screening/ Mon, 18 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115003 An interview study with patients with mNSCLC revealed patients’ values regarding information about their disease, its treatment, and their prognosis and expectations.]]> https://www.oncologynurseadvisor.com/reports/myelodysplastic-syndrome-mds-iron-chelation-therapy-treatment-risk/ Mon, 18 Dec 2023 15:50:00 +0000 https://www.oncologynurseadvisor.com/?p=115001 An analysis of more than 2500 patients with low-risk MDS highlighted the benefits of iron chelation to reduce transfusion-related iron overload.]]> https://www.oncologynurseadvisor.com/home/hot-topics/side-effect-management/cancer-acupuncture-massage-equivalent-symptom-management-treatment/ Fri, 15 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=114973 Randomized trial found acupuncture and massage beneficial in relieving pain in patients with advanced pain, with little difference in effect between the 2 modalities.]]> https://www.oncologynurseadvisor.com/reports/nk-cell-neoplasm-second-third-line-therapy-survival-treatment-risk/ Wed, 13 Dec 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=114915 Researchers sought to determine the effects of second-line to third-line therapy sequence for relapsed/refractory T and NK-cell neoplasms on OS and real world PFS.]]> https://www.oncologynurseadvisor.com/reports/bronchitis-obliterans-gvhd-graft-host-disease-allo-hsct-type-tcell-key/ Mon, 11 Dec 2023 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=114840 Researchers explored the pathogenesis of bronchiolitis obliterans syndrome as a late-effect of cGVHD in patients undergoing allo-HSCT.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2023/emapalumab-for-management-post-hsct-graft-failure/ Sun, 10 Dec 2023 18:50:00 +0000 https://www.oncologynurseadvisor.com/?p=114800 Researchers sought to determine the safety and efficacy of emapalumab as treatment and prophylaxis of graft failure in post-HSCT patients.]]> https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2023/frontline-therapy-intensity-outcomes-age-specific-in-elderly-dlbcl/ Sun, 10 Dec 2023 17:27:44 +0000 https://www.oncologynurseadvisor.com/?p=114782 Researchers investigated the efficacy of several frontline treatment strategies in older patients with DLBCL.]]>